Cytosorbents CorporationCTSONASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank21
Studio
Year-over-Year Change

Return on equity

Latest
-186.54%
↓ 253% vs avg
Percentile
P21
Within normal range
Streak
4 yr
Consecutive declineContracting
Average
121.74%
Historical baseline
PeriodValueYoY Change
2024-186.54%-48.5%
2023-125.66%-35.5%
2022-92.76%-136.4%
2021-39.24%-296.7%
2020-9.89%+98.2%
2019-563.66%-454.6%
2018-101.63%-23.3%
2017-82.44%-103.3%
20162518.28%+2642.7%
2015-99.04%-